Back to search

Article

Fremanezumab in the Prevention of High-Frequency Episodic and Chronic Migraine: A 12-Week, Multicenter, Real-Life, Cohort Study (The FRIEND Study).

2021-12-28

Abstract excerpt

<title>Abstract</title> <p>Background Fremanezumab has demonstrated to be effective, safe, and tolerated in the prevention of episodic or chronic migraine (CM) in randomized, placebo-controlled trials (RCTs). Real-life studies are needed to explore drug effects in unselected patients in routine circumstances and to provide higher generalizability results. This study explores the effectiveness, safety, and tolera...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
190bfddf-14ff-59f1-a38e-03fa997bd017
DOI
10.21203/rs.3.rs-1175049/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Fremanezumab in the Prevention of High-Frequency Episodic and Chronic Migraine: A 12-Week, Multicenter, Real-Life, Cohort Study (The FRIEND Study).DOI 10.21203/rs.3.rs-1175049/v1
Real-world experience of erenumab in patients with chronic or episodic migraine in the UAESemantic proximity
Two-year, real-world erenumab persistence and quality of life data in 82 pooled patients with abrupt onset, unremitting, treatment refractory headache and a migraine phenotype: New daily persistent headache or persistent post-traumatic headache in the majority of cases.Semantic proximity
Efficacy of fremanezumab in refractory chronic migraine patients: Real-world data from the Hull Migraine Clinic, UKSemantic proximity
Unveiling the Efficacy and Safety of Erenumab, a Monoclonal Antibody Targeting Calcitonin Gene-related Peptide (CGRP) Receptor, in Patients with Chronic and Episodic Migraine: A GRADE-assessed Systematic Review and Meta-analysis of Randomized Clinical Trials with Subgroup AnalysisSemantic proximity
Epidemiological, clinical characterization and treatment patterns of migraine patients in a Colombian cohort from 2018 to 2022.Semantic proximity
Migraine in men – differences in phenotype and treatment patterns: Results from the Migraine in Poland cross-sectional national surveySemantic proximity
Safety and Efficacy of Fremanezumab for the Prevention of Migraine: a Meta-analysis from Random Clinical TrailsSemantic proximity
Predictors of galcanezumab response in a real-world study of Korean patients with migraineSemantic proximity
Different Doses of Erenumab for Preventive Treatment of Episodic Migraine: A Systematic Review and Network Meta-AnalysisSemantic proximity
Different Dosage Regimens of Eptinezumab for the Treatment of Migraine: A Meta-Analysis from Randomized Controlled TrialsSemantic proximity
Migraine: disease characterisation, biomarkers, and precision medicineSemantic proximity
Acute and preventive treatment of COVID-19 related headache: A series of 100 patientsSemantic proximity
Select a neighboring publication to make it the new centre.